Psilocybin（赛洛西宾）作为5-羟色胺受体的激动剂可通过促进皮层突触新生，增强突触功能发挥抗抑郁症作用。临床研究表明一至两个疗程的Psilocybin ...

Psilocybin, a classic psychedelic, has therapeutic potential for psychiatric disorders. A specific brain circuit and receptor have now been found to be required for psilocybin’s long-term ...

Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found.

The paper is titled "Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the ...

Relmada Therapeutics’ attempts to see whether a magic mushroom extract could be used to treat obesity and metabolic diseases may be coming to an end before they really began. The biotech ...

Psilocybin is the active ingredient that gives so-called "magic mushrooms" their hallucinogenic kick. It also has a therapeutic potential for treating depression. Cornell researchers have ...

Psilocybin use increased across all age groups in the US following its 2019 decriminalization, with notable rises among young adults (44%), older adults (188%), and 12th graders (53%).

But in the psilocybin-treated group, the swelling was significantly reduced. MRI scans revealed that their brain ...

Psilocybin Use Dramatically Increasing In U.S. By Dennis Thompson HealthDay Reporter WEDNESDAY, April 23, 2025 (HealthDay News) — Recreational use of “magic mushroom” psilocybin skyrocketed ...